Genmab Future Growth
Future criteria checks 4/6
Genmab is forecast to grow earnings and revenue by 28.9% and 19% per annum respectively. EPS is expected to grow by 27.8% per annum. Return on equity is forecast to be 19.9% in 3 years.
Key information
28.9%
Earnings growth rate
27.8%
EPS growth rate
Biotechs earnings growth | 30.2% |
Revenue growth rate | 19.0% |
Future return on equity | 19.9% |
Analyst coverage | Good |
Last updated | n/a |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2024 | 18,268 | 7,021 | 6,316 | 6,670 | 18 |
12/31/2023 | 15,206 | 5,182 | 4,361 | 4,728 | 21 |
12/31/2022 | 12,267 | 3,863 | 3,018 | 3,282 | 25 |
3/31/2022 | 9,020 | 2,377 | 1,349 | 1,630 | N/A |
12/31/2021 | 8,482 | 3,008 | 1,976 | 2,228 | N/A |
9/30/2021 | 7,907 | 2,873 | 947 | 1,189 | N/A |
6/30/2021 | 7,321 | 2,513 | 5,609 | 5,820 | N/A |
3/31/2021 | 10,800 | 5,585 | 5,427 | 5,704 | N/A |
12/31/2020 | 10,111 | 4,758 | 6,126 | 6,433 | N/A |
9/30/2020 | 11,028 | 5,649 | 7,128 | 7,406 | N/A |
6/30/2020 | 10,344 | 5,656 | 2,369 | 2,647 | N/A |
3/31/2020 | 5,667 | 2,363 | 2,444 | 2,592 | N/A |
12/31/2019 | 5,366 | 2,166 | 1,215 | 1,326 | N/A |
9/30/2019 | 3,641 | 1,528 | 1,252 | 1,355 | N/A |
6/30/2019 | 3,199 | 1,170 | 782 | 1,248 | N/A |
3/31/2019 | 2,935 | 1,345 | 729 | 1,199 | N/A |
12/31/2018 | 3,025 | 1,472 | 537 | 1,015 | N/A |
9/30/2018 | 2,807 | 1,424 | 583 | 1,062 | N/A |
6/30/2018 | 2,532 | 1,239 | 796 | 892 | N/A |
3/31/2018 | 2,796 | 1,286 | 1,188 | 1,301 | N/A |
12/31/2017 | 2,365 | 1,104 | 1,500 | 1,589 | N/A |
9/30/2017 | 2,275 | 1,159 | 1,168 | 1,260 | N/A |
6/30/2017 | 2,316 | 1,354 | 1,356 | 1,422 | N/A |
3/31/2017 | 1,897 | 1,215 | 1,055 | 1,088 | N/A |
12/31/2016 | 1,816 | 1,187 | 295 | 328 | N/A |
9/30/2016 | 1,463 | 735 | 634 | 658 | N/A |
6/30/2016 | 1,376 | 686 | 566 | 591 | N/A |
3/31/2016 | 1,196 | 535 | 238 | 358 | N/A |
12/31/2015 | 1,133 | 764 | N/A | 311 | N/A |
9/30/2015 | 774 | 443 | N/A | 70 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: GE9's forecast earnings growth (28.9% per year) is above the savings rate (-0.01%).
Earnings vs Market: GE9's earnings (28.9% per year) are forecast to grow faster than the German market (14.5% per year).
High Growth Earnings: GE9's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: GE9's revenue (19% per year) is forecast to grow faster than the German market (4.6% per year).
High Growth Revenue: GE9's revenue (19% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: GE9's Return on Equity is forecast to be low in 3 years time (19.9%).